Login to Your Account



Second Genome inks microbiome deal with Pfizer

By Michael Fitzhugh
Staff Writer

Thursday, May 1, 2014
Second Genome Inc. is partnering with Pfizer Inc. on a large observational study exploring the relationship between the trillions of microorganisms comprising the human microbiome and obesity and metabolic disorders.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription